Adrenergic agonists, vasopressors and inotropes
Catecholamines and synthetic sympathomimetics, how their receptor profiles predict their effects, the non-adrenergic vasopressors and inotropes, and how to choose between them in shock.
By the end of this page you should be able to
- Classify sympathomimetics by receptor selectivity and by direct or indirect action.
- Describe the pharmacology of adrenaline, noradrenaline, dobutamine, dopamine, isoprenaline, metaraminol and phenylephrine.
- Describe the pharmacology of vasopressin, milrinone and levosimendan.
- Explain why catecholamines are inactive orally and short-acting.
- Choose a vasoactive agent for septic, cardiogenic and anaphylactic shock and justify the choice.
Classification
- Catecholamines (a catechol ring plus an amine): adrenaline, noradrenaline, dopamine (endogenous); dobutamine, isoprenaline (synthetic). Rapidly broken down by COMT and MAO and taken up by neurons: not active orally, half-lives of about 2 minutes, given by infusion.
- Non-catecholamines: phenylephrine, metaraminol, ephedrine, salbutamol. Resistant to COMT, so longer acting and, for some, active orally.
- Direct acting: bind adrenoceptors (adrenaline, noradrenaline, phenylephrine, dobutamine, salbutamol).
- Indirect acting: release noradrenaline from nerve terminals (amphetamine, tyramine) or block its reuptake (cocaine). Show tachyphylaxis as stores run down and are ineffective in depleted states.
- Mixed: ephedrine, metaraminol, dopamine.
Receptor effects to predict from
- Alpha-1 (Gq): arteriolar and venous constriction, raising SVR and venous return; reflex bradycardia; mydriasis.
- Alpha-2 (Gi): presynaptic inhibition of noradrenaline release; central sympatholysis (clonidine, dexmedetomidine).
- Beta-1 (Gs): rate, contractility, conduction, renin. Raises myocardial oxygen demand.
- Beta-2 (Gs): bronchodilation, vasodilation in muscle (lowers diastolic pressure), glycogenolysis, lactate, potassium into cells, uterine relaxation, mast cell stabilisation.
- D1: renal and mesenteric vasodilation (low-dose dopamine, which does not protect the kidney).
The drugs
- Adrenaline: alpha and beta. Low doses: mostly beta (raised cardiac output, lower diastolic pressure from beta-2 vasodilation). High doses: alpha dominates. Uses: cardiac arrest, anaphylaxis (IM; beta-2 also stabilises mast cells and bronchodilates), severe asthma, croup (nebulised), shock refractory to noradrenaline, symptomatic bradycardia. Raises lactate and glucose and lowers potassium.
- Noradrenaline: potent alpha-1 with moderate beta-1, little beta-2. Raises SVR and mean arterial pressure; heart rate often falls (baroreflex); cardiac output roughly unchanged. First-line in septic shock.
- Dobutamine: synthetic, mainly beta-1 with some beta-2 and alpha-1 (the racemate balances out the vascular effects). An inotrope that raises cardiac output and may lower SVR; can cause hypotension and tachyarrhythmias. Used in low-output cardiac failure with adequate blood pressure, and for stress echocardiography.
- Dopamine: dose-dependent: D1 at low doses, beta-1 at moderate doses, alpha-1 at high doses (with indirect noradrenaline release). More arrhythmias than noradrenaline in shock; now rarely first-line.
- Isoprenaline: pure beta-1 and beta-2 agonist. Raises heart rate and conduction (bradycardia, heart block awaiting pacing, torsades) and drops diastolic pressure.
- Metaraminol: direct alpha-1 agonist with indirect noradrenaline release; bolus or infusion, onset 1 to 2 minutes, lasts about 20 minutes. Popular for peri-intubation hypotension in Australasian EDs; reflex bradycardia; tachyphylaxis.
- Phenylephrine: pure alpha-1. Raises pressure with reflex bradycardia; useful when tachycardia is unwanted (hypertrophic obstructive cardiomyopathy, aortic stenosis) and in obstetric spinal hypotension.
- Ephedrine: mixed direct and indirect alpha and beta; raises heart rate and pressure; tachyphylaxis.
Non-adrenergic agents
- Vasopressin: V1 receptors on vascular smooth muscle (Gq) cause vasoconstriction independent of adrenoceptors (useful in acidosis, when catecholamine receptors respond poorly); V2 receptors in the collecting duct (water retention); relative vasopressin deficiency develops in septic shock. Added to noradrenaline to reduce the catecholamine dose. Adverse: digital, mesenteric and coronary ischaemia. Terlipressin is a longer-acting analogue used in variceal bleeding and hepatorenal syndrome.
- Milrinone: phosphodiesterase 3 inhibitor; raises cAMP in heart (inotropy, lusitropy) and vessels (vasodilation): an inodilator. Works when beta receptors are down-regulated or blocked. Renally cleared, long half-life; hypotension and arrhythmias.
- Levosimendan: calcium sensitiser (binds troponin C) and K-ATP opener (vasodilation); active metabolite lasts days.
- Glucagon and high-dose insulin bypass the beta receptor in beta blocker poisoning; calcium in calcium channel blocker poisoning.
- Methylene blue inhibits nitric oxide-cGMP signalling and can raise pressure in vasoplegia; contraindicated in G6PD deficiency and with serotonergic drugs.
Choosing in shock
Start with the problem. Septic (distributive) shock: after fluids, noradrenaline to a mean arterial pressure target (commonly 65 mmHg), adding vasopressin or adrenaline if needed, with hydrocortisone for refractory shock. Cardiogenic shock: the heart is failing and vasoconstriction raises afterload; an inotrope (dobutamine, adrenaline or milrinone) with noradrenaline to support pressure, and treatment of the cause (reperfusion). Anaphylaxis: adrenaline IM first, then infusion if shock persists. Neurogenic shock: noradrenaline (or phenylephrine) with atropine or a beta agonist for bradycardia. Hypovolaemic shock: volume and haemorrhage control; vasopressors only bridge.
Peripheral administration of dilute vasopressors through a large, well-sited cannula for a short time is accepted practice, with close watching for extravasation.
Making the answer flow
- Predict effects from the receptor profile, then add reflexes: "Phenylephrine raises SVR, so pressure rises and the baroreflex slows the heart."
- Distinguish vasopressor (raises SVR) from inotrope (raises contractility) and inodilator (both inotropy and vasodilation).
- Tie the choice to the haemodynamic profile of the shock state.
Where marks are lost
- Saying noradrenaline causes tachycardia. It usually slows the heart through the baroreflex.
- Claiming low-dose dopamine protects the kidneys.
- Forgetting that adrenaline lowers diastolic pressure at low doses (beta-2).
- Calling a raised lactate on adrenaline proof of hypoperfusion.
Where this meets anaesthesia
- Metaraminol and phenylephrine raise pressure by vasoconstriction and can cause reflex bradycardia; ephedrine also acts indirectly and raises heart rate.
- Indirect sympathomimetics such as ephedrine show tachyphylaxis as noradrenaline stores are depleted.
Viva questions
Answer each one aloud, as you would to an examiner, before you open the model points.
- 1.
Compare adrenaline and noradrenaline.
Show answer
- Both endogenous catecholamines; COMT, MAO and reuptake; half-life about 2 minutes; IV infusion.
- Adrenaline: alpha-1, alpha-2, beta-1, beta-2; dose-dependent; raises cardiac output; low dose lowers diastolic BP; metabolic effects (glucose, lactate, potassium down).
- Noradrenaline: alpha predominant with beta-1; raises SVR and MAP; reflex bradycardia; little metabolic effect.
- Uses: adrenaline in arrest and anaphylaxis; noradrenaline in septic shock.
- 2.
Why are catecholamines given intravenously and by infusion?
Show answer
- Polar molecules with a catechol ring: extensive gut and hepatic metabolism by COMT and MAO; negligible oral bioavailability.
- Rapid termination by neuronal reuptake and enzymatic breakdown: half-lives of minutes.
- Infusion gives steady effect and titration; IM adrenaline is an exception for anaphylaxis.
- 3.
A patient with septic shock remains hypotensive on increasing noradrenaline. What are your pharmacological options?
Show answer
- Check volume status, source control, and line function.
- Add vasopressin (non-adrenergic V1 vasoconstriction; corrects relative deficiency; catecholamine-sparing).
- Add adrenaline (inotropy if septic cardiomyopathy).
- Hydrocortisone (restores vascular responsiveness, relative adrenal insufficiency).
- Correct acidosis, calcium; consider methylene blue or angiotensin II in refractory vasoplegia where available.
- 4.
Describe the pharmacology of dobutamine.
Show answer
- Synthetic catecholamine; racemic mixture: (+) is beta-1 and beta-2 agonist and alpha-1 antagonist; (minus) is alpha-1 agonist.
- Net beta-1 effect: increased contractility and cardiac output; modest chronotropy; SVR unchanged or reduced.
- Half-life about 2 minutes; infusion.
- Adverse: tachycardia, arrhythmias, hypotension, myocardial ischaemia; tolerance over days.
- Uses: cardiogenic shock with adequate pressure, stress echocardiography.
- 5.
What is metaraminol and why is it popular in the emergency department?
Show answer
- Synthetic non-catecholamine, direct alpha-1 agonist with indirect noradrenaline release, weak beta.
- Bolus or infusion; onset 1 to 2 minutes; duration about 20 minutes.
- Peripheral use, easy preparation; treats vasodilatory hypotension after induction.
- Limitations: reflex bradycardia, may lower cardiac output in a failing heart, tachyphylaxis, does not treat hypovolaemia.
- 6.
How does milrinone work and when would you use it?
Show answer
- Inhibits PDE3, raising cAMP in myocardium and vascular smooth muscle.
- Positive inotropy and lusitropy with vasodilation (inodilator), lowering SVR and PVR.
- Independent of beta receptors: useful with beta blockade or receptor down-regulation in chronic heart failure; right ventricular failure with pulmonary hypertension.
- Renal elimination; long half-life (hours); hypotension and arrhythmias.
- 7.
Explain the role of vasopressin in shock.
Show answer
- Endogenous peptide from posterior pituitary; V1 (vasoconstriction via Gq and IP3), V2 (aquaporin insertion), V3 (ACTH).
- In septic shock, levels are inappropriately low after the initial surge; vascular response to catecholamines is impaired by acidosis and NO.
- Low-dose infusion restores tone and spares noradrenaline.
- Adverse: digital and splanchnic ischaemia, hyponatraemia, reduced cardiac output.
- 8.
What is tachyphylaxis? Which sympathomimetics show it?
Show answer
- Rapidly diminishing response to repeated doses.
- Indirect agents (ephedrine, metaraminol, amphetamines, tyramine) deplete releasable noradrenaline stores.
- Also receptor desensitisation with prolonged agonist exposure (beta receptors in chronic heart failure or prolonged dobutamine).
- 9.
Why does adrenaline work in anaphylaxis when antihistamines do not?
Show answer
- Alpha-1: vasoconstriction restores SVR and venous return, reduces mucosal oedema.
- Beta-1: inotropy and chronotropy.
- Beta-2: bronchodilation and inhibition of mast cell and basophil mediator release (cAMP).
- Physiological antagonism of all mediators, not just histamine; antihistamines act only at H1 and only on skin symptoms in practice.
- IM into the anterolateral thigh for rapid, reliable absorption.
Practise this week
- Primary MCQs: pharmacology
- Primary SAQs, marked part by part
- Primary vivas
- Viva Examiner: practise answering aloud
Week 8 in the other subjects
- Physiology: Cardiac electrophysiology and the ECG
- Measurement and equipment: Electricity, electrical safety and diathermy
Not affiliated with the Australian and New Zealand College of Anaesthetists (ANZCA). Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.